CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Harnessing advanced data analysis for early detection, prevention and better outcomes
Subscribe To Our Newsletter & Stay Updated